208 related articles for article (PubMed ID: 12663879)
1. Is thrombogenesis in atrial fibrillation related to matrix metalloproteinase-1 and its inhibitor, TIMP-1?
Marín F; Roldán V; Climent V; Garcia A; Marco P; Lip GY
Stroke; 2003 May; 34(5):1181-6. PubMed ID: 12663879
[TBL] [Abstract][Full Text] [Related]
2. Statins and postoperative risk of atrial fibrillation following coronary artery bypass grafting.
Marín F; Pascual DA; Roldán V; Arribas JM; Ahumada M; Tornel PL; Oliver C; Gómez-Plana J; Lip GY; Valdés M
Am J Cardiol; 2006 Jan; 97(1):55-60. PubMed ID: 16377284
[TBL] [Abstract][Full Text] [Related]
3. MMP-9 in atrial remodeling in patients with atrial fibrillation.
Lewkowicz J; Knapp M; Tankiewicz-Kwedlo A; Sawicki R; Kamińska M; Waszkiewicz E; Musiał WJ
Ann Cardiol Angeiol (Paris); 2015 Sep; 64(4):285-91. PubMed ID: 25869465
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases in rapid atrial pacing-induced atrial fibrillation.
Chen CL; Huang SK; Lin JL; Lai LP; Lai SC; Liu CW; Chen WC; Wen CH; Lin CS
J Mol Cell Cardiol; 2008 Dec; 45(6):742-53. PubMed ID: 18692064
[TBL] [Abstract][Full Text] [Related]
5. [Effects of matrix metalloproteinase-9 and tissue inhibitor-1 of metalloproteinase expression on atrial structural remodeling during chronic atrial fibrillation].
Zhu H; Zhang W; Guo CH; Zhang G; Zhang WD; Zhong M; Yang GR; Ge ZM; Zhang Y
Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(1):45-8. PubMed ID: 15808077
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase-9 contributes to human atrial remodeling during atrial fibrillation.
Nakano Y; Niida S; Dote K; Takenaka S; Hirao H; Miura F; Ishida M; Shingu T; Sueda T; Yoshizumi M; Chayama K
J Am Coll Cardiol; 2004 Mar; 43(5):818-25. PubMed ID: 14998623
[TBL] [Abstract][Full Text] [Related]
7. The role of pro-fibrotic biomarkers in paroxysmal and persistent atrial fibrillation.
Stanciu AE; Vatasescu RG; Stanciu MM; Serdarevic N; Dorobantu M
Cytokine; 2018 Mar; 103():63-68. PubMed ID: 29324263
[TBL] [Abstract][Full Text] [Related]
8. MMP-2 and TIMP-2 gene polymorphisms and susceptibility to atrial fibrillation in Chinese Han patients with hypertensive heart disease.
Gai X; Zhang Z; Liang Y; Chen Z; Yang X; Hou J; Lan X; Zheng W; Hou J; Huang M
Clin Chim Acta; 2010 May; 411(9-10):719-24. PubMed ID: 20138860
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinases and atrial remodeling in patients with mitral valve disease and atrial fibrillation.
Anné W; Willems R; Roskams T; Sergeant P; Herijgers P; Holemans P; Ector H; Heidbüchel H
Cardiovasc Res; 2005 Sep; 67(4):655-66. PubMed ID: 15913581
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension and their relationship to cardiovascular risk and treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
Tayebjee MH; Nadar S; Blann AD; Gareth Beevers D; MacFadyen RJ; Lip GY
Am J Hypertens; 2004 Sep; 17(9):764-9. PubMed ID: 15363817
[TBL] [Abstract][Full Text] [Related]
11. Tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9 levels in patients with hypertension Relationship to tissue Doppler indices of diastolic relaxation.
Tayebjee MH; Nadar SK; MacFadyen RJ; Lip GY
Am J Hypertens; 2004 Sep; 17(9):770-4. PubMed ID: 15363818
[TBL] [Abstract][Full Text] [Related]
12. [Changes in gelatinases expression and activity in human atria during atrial fibrillation].
Ke D; Xu CX; Zhang JC; Chen L; Lin YZ; Lin LF; Hu XZ
Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Feb; 33(2):137-42. PubMed ID: 15924808
[TBL] [Abstract][Full Text] [Related]
13. Novel association patterns of cardiac remodeling markers in patients with essential hypertension and atrial fibrillation.
Kalogeropoulos AS; Tsiodras S; Rigopoulos AG; Sakadakis EA; Triantafyllis A; Kremastinos DT; Rizos I
BMC Cardiovasc Disord; 2011 Dec; 11():77. PubMed ID: 22204652
[TBL] [Abstract][Full Text] [Related]
14. Impact of biomarkers of inflammation and extracellular matrix turnover on the outcome of atrial fibrillation ablation: importance of matrix metalloproteinase-2 as a predictor of atrial fibrillation recurrence.
Okumura Y; Watanabe I; Nakai T; Ohkubo K; Kofune T; Kofune M; Nagashima K; Mano H; Sonoda K; Kasamaki Y; Hirayama A
J Cardiovasc Electrophysiol; 2011 Sep; 22(9):987-93. PubMed ID: 21489023
[TBL] [Abstract][Full Text] [Related]
15. Atrial fibrillation and hypercoagulability: dependent on clinical factors or/and on genetic alterations?
Hatzinikolaou-Kotsakou E; Kartasis Z; Tziakas D; Hotidis A; Stakos D; Tsatalas K; Bourikas G; Kotsakou ME; Hatseras DI
J Thromb Thrombolysis; 2003 Dec; 16(3):155-61. PubMed ID: 15087601
[TBL] [Abstract][Full Text] [Related]
16. [Clinical on molecular basis of atrial fibrosis in patients with atrial fibrillation investigation].
Ke D; Xu CX; Lin YZ; Zhang JC; Chen L; Lin LF; Hu XZ
Zhonghua Xin Xue Guan Bing Za Zhi; 2005 May; 33(5):459-63. PubMed ID: 15932710
[TBL] [Abstract][Full Text] [Related]
17. [Metalloproteinase activity of the blood in patients with arterial hypertension with paroxysmal form of atrial fibrillation].
Khezheva FM; Mazur NA; Masenko VP
Kardiologiia; 2007; 47(12):10-4. PubMed ID: 18260972
[TBL] [Abstract][Full Text] [Related]
18. Plasma matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-2, and CD40 ligand levels in patients with stable coronary artery disease.
Tayebjee MH; Lip GY; Tan KT; Patel JV; Hughes EA; MacFadyen RJ
Am J Cardiol; 2005 Aug; 96(3):339-45. PubMed ID: 16054454
[TBL] [Abstract][Full Text] [Related]
19. Circulating matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases-1 and -2 levels in gestational hypertension.
Tayebjee MH; Karalis I; Nadar SK; Beevers DG; MacFadyen RJ; Lip GY
Am J Hypertens; 2005 Mar; 18(3):325-9. PubMed ID: 15797648
[TBL] [Abstract][Full Text] [Related]
20. Extracellular matrix alterations in patients with paroxysmal and persistent atrial fibrillation: biochemical assessment of collagen type-I turnover.
Kallergis EM; Manios EG; Kanoupakis EM; Mavrakis HE; Arfanakis DA; Maliaraki NE; Lathourakis CE; Chlouverakis GI; Vardas PE
J Am Coll Cardiol; 2008 Jul; 52(3):211-5. PubMed ID: 18617070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
